Because uPA binding to the uPA receptor increases the binding affinity of vitronectin to the uPA receptor [46], a blockade of PAI-1 can reduce cancer cell migration, proliferation, and survival by increasing cell adhesion to the ECM through the promotion of uPA receptor binding to vitronectin [47,48]. Here, PLAU is linked to cancer.